Trillium Therapeutics Announces Publication Highlighting Activity of TTI-621 in Sézary Syndrome Patients

NEXT STORY
Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs
PREV STORY
Global Over The Counter/OTC Test Market 2018-2019 & 2024: Leading Players Focus on Organic and Inorganic Growth Strategies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AnHeart Announces Publication of Pooled Analysis of two Phase 1 Studies of Taletrectinib in ROS1+ NSCLC

author_avatar
NASDAQ Market News

Gene Therapy Market is Likely to grow at the CAGR of 33.3% from 2017 to 2023

author_avatar
NASDAQ Market News

Zai Lab Announces Upcoming Participation in the BofA Securities 2020 Health Care Conference

author_avatar
NASDAQ Market News